1Suppliers
15Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

ALX Oncology Holdings Inc. (ALXO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships
1Distinct source URLs
5High confidence
0.721Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

ALX Oncology Holdings Inc. Suppliers

TickerNameConfidenceEvidence
PHARMACEUTICAL-CONTRACT-MANUFACTURERS-AND-SUPPLI PHARMACEUTICAL-CONTRACT-MANUFACTURERS-AND-SUPPLI 92% The Company has commitments with two other pharmaceutical contract manufacturers and suppliers, including certain future purchase obligations of approximately $ 1.7 million

ALX Oncology Holdings Inc. Customers

TickerNameConfidenceEvidence
FCNCB First Citizens BancShares, Inc. 72% from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
FCNCB First Citizens BancShares, Inc. 72% Reciprocal relationship from FCNCB graph: Reciprocal relationship from ALXO graph: Reciprocal relationship from FCNCB graph: Reciprocal relationship from ALXO graph: from the reduction in workforce, …
JAZZ Jazz Pharmaceuticals plc 72% ns and Other Commitments The Company has other contractual obligations and other commitments from manufacturing and service contracts, which are presented as follows as of March 31, 2026 (in thousand…
JAZZ Jazz Pharmaceuticals plc 72% Reciprocal relationship from JAZZ graph: Reciprocal relationship from ALXO graph: ns and Other Commitments The Company has other contractual obligations and other commitments from manufacturing and s…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from ALXO graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from ALXO graph: ted by movements in our stock pri…
SNYNF Sanofi 72% ted by movements in our stock price that are beyond our control and therefore any declining value in our equity grants could negatively impact our ability to successfully retain existing employees or…
ALX-ONCOLOGY-LIMITED ALX-ONCOLOGY-LIMITED 62% s placed into receivership with the FDIC, and all funds held at SVB were temporarily inaccessible to SVB’s customers. If other banks and financial institutions with whom we have banking relationships…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% s placed into receivership with the FDIC, and all funds held at SVB were temporarily inaccessible to SVB’s customers. If other banks and financial institutions with whom we have banking relationships…
KBI-BIOPHARMA-INC KBI-BIOPHARMA-INC 62% . The Company may terminate this ATM program at any time, pursuant to its terms. Pre-Funded Warrants In October 2023, the Company completed a registered offering (the October 2023 Offering) pursuant …
NASDAQ-STOCK-MARKET-LLC NASDAQ-STOCK-MARKET-LLC 62% ted by movements in our stock price that are beyond our control and therefore any declining value in our equity grants could negatively impact our ability to successfully retain existing employees or…
OXFORD-FINANCE-LLC OXFORD-FINANCE-LLC 62% from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
SVB-FIRST-CITIZENS-BANCSHARES-INC SVB-FIRST-CITIZENS-BANCSHARES-INC 62% from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
TALLAC-THERAPEUTICS-INC TALLAC-THERAPEUTICS-INC 62% . The Company may terminate this ATM program at any time, pursuant to its terms. Pre-Funded Warrants In October 2023, the Company completed a registered offering (the October 2023 Offering) pursuant …
UBS-SECURITIES-LLC UBS-SECURITIES-LLC 62% from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
USA-LLC USA-LLC 62% from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…

ALX Oncology Holdings Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALXO-DEBT-7707 Warrants outstanding: 61292 90% xbrl warrant detail from xbrl 2026-03-31.
ALXO-DEBT Debt stack $9.7M 90% Market cache reports total debt of $9.7M.
ALXO-DEBT-7708 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

ALX Oncology Holdings Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ALX Oncology Holdings Inc..

ALX Oncology Holdings Inc. Ownership

HolderNameConfidenceEvidence
ALXO-OWNER-RA-CAPITAL-MANAGEMENT-L-P RA CAPITAL MANAGEMENT, L.P. 90% 13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 72 tracked holders.

ALX Oncology Holdings Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CALC CalciMedica, Inc. 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ADAG Adagene Inc. 100.00 2
🔐
ALXO
Unlock ALXO Supply Chain Data
Verified relationships include:
PHARMACEUTICAL-CONTRACT-MANUFACTURERS-AND-SUPPLIPHARMACEUTICAL-CONTRACT-M…Supplier92%
FCNCBFirst Citizens BancShares, Inc.Customer72%
FCNCBFirst Citizens BancShares, Inc.Customer72%
+16 more relationships locked
Subscribe — View plans →